mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-09 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
4e-08 |